The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma

被引:173
作者
Steen, Chloe [1 ,2 ]
Luca, Bogdan [2 ,3 ]
Esfahani, Mohammad [1 ]
Azizi, Armon [2 ]
Sworder, Brian [1 ]
Nabet, Barzin [4 ]
Kurtz, David [1 ]
Liu, Chih [1 ]
Khameneh, Farnaz [2 ]
Advani, Ranjana [1 ]
Natkunam, Yasodha [5 ]
Myklebust, June [6 ,7 ]
Diehn, Maximilian [4 ]
Gentles, Andrew [2 ,3 ,9 ]
Newman, Aaron [2 ,8 ,9 ]
Alizadeh, Ash [1 ,8 ,9 ]
机构
[1] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA
[3] Stanford Univ, Stanford Ctr Biomed Informat Res, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Radiat Oncol, Med Ctr, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Pathol, Med Ctr, Stanford, CA 94305 USA
[6] Oslo Univ Hosp, Inst Canc Res, Dept Canc Immunol, Oslo, Norway
[7] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Inst Clin Med, Oslo, Norway
[8] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[9] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA
关键词
GENE-EXPRESSION; BRENTUXIMAB VEDOTIN; PD-1; BLOCKADE; NIVOLUMAB; RITUXIMAB; SUBSETS; DISEASE; MICROENVIRONMENT; CLASSIFICATION; PEMBROLIZUMAB;
D O I
10.1016/j.ccell.2021.08.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Biological heterogeneity in diffuse large B cell lymphoma (DLBCL) is partly driven by cell-of-origin subtypes and associated genomic lesions, but also by diverse cell types and cell states in the tumor microenvironment (TME). However, dissecting these cell states and their clinical relevance at scale remains challenging. Here, we implemented EcoTyper, a machine-learning framework integrating transcriptome deconvolution and single-cell RNA sequencing, to characterize clinically relevant DLBCL cell states and ecosystems. Using this approach, we identified five cell states of malignant B cells that vary in prognostic associations and differentiation status. We also identified striking variation in cell states for 12 other lineages comprising the TME and forming cell state interactions in stereotyped ecosystems. While cell-of-origin subtypes have distinct TME composition, DLBCL ecosystems capture clinical heterogeneity within existing subtypes and extend beyond cell-of-origin and genotypic classes. These results resolve the DLBCL microenvironment at systems-level resolution and identify opportunities for therapeutic targeting (https://ecotyper.stanford.eduilymphoma).
引用
收藏
页码:1422 / +
页数:26
相关论文
共 94 条
[21]   Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].
Chapuy, Bjoern ;
Stewart, Chip ;
Dunford, Andrew J. ;
Kim, Jaegil ;
Kamburov, Atanas ;
Redd, Robert A. ;
Lawrence, Mike S. ;
Roemer, Margaretha G. M. ;
Li, Amy J. ;
Ziepert, Marita ;
Staiger, Annette M. ;
Wala, Jeremiah A. ;
Ducar, Matthew D. ;
Leshchiner, Ignaty ;
Rheinbay, Ester ;
Taylor-Weiner, Amaro ;
Coughlin, Caroline A. ;
Hess, Julian M. ;
Pedamallu, Chandra S. ;
Livitz, Dimitri ;
Rosebrock, Daniel ;
Rosenberg, Mara ;
Tracy, Adam A. ;
Horn, Heike ;
van Hummelen, Paul ;
Feldman, Andrew L. ;
Link, Brian K. ;
Novak, Anne J. ;
Cerhan, James R. ;
Habermann, Thomas M. ;
Siebert, Reiner ;
Rosenwald, Andreas ;
Thorner, Aaron R. ;
Meyerson, Matthew L. ;
Golub, Todd R. ;
Beroukhim, Rameen ;
Wulf, Gerald G. ;
Ott, German ;
Rodig, Scott J. ;
Monti, Stefano ;
Neuberg, Donna S. ;
Loeffler, Markus ;
Pfreundschuh, Michael ;
Truemper, Lorenz ;
Getz, Gad ;
Shipp, Margaret A. .
NATURE MEDICINE, 2018, 24 (05) :679-+
[22]   ToppGene Suite for gene list enrichment analysis and candidate gene prioritization [J].
Chen, Jing ;
Bardes, Eric E. ;
Aronow, Bruce J. ;
Jegga, Anil G. .
NUCLEIC ACIDS RESEARCH, 2009, 37 :W305-W311
[23]   Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].
Chen, Robert ;
Zinzani, Pier Luigi ;
Fanale, Michelle A. ;
Armand, Philippe ;
Johnson, Nathalie A. ;
Brice, Pauline ;
Radford, John ;
Ribrag, Vincent ;
Molin, Daniel ;
Vassilakopoulos, Theodoros P. ;
Tomita, Akihiro ;
von Tresckow, Bastian ;
Shipp, Margaret A. ;
Zhang, Yinghua ;
Ricart, Alejandro D. ;
Balakumaran, Arun ;
Moskowitz, Craig H. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+
[24]   CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity [J].
Chu, Fuliang ;
Li, Haiyan S. ;
Liu, Xindong ;
Cao, Jingjing ;
Ma, Wencai ;
Ma, Ying ;
Weng, Jinsheng ;
Zhu, Zheng ;
Cheng, Xiaoyun ;
Wang, Zhiqiang ;
Liu, Jingwei ;
Jiang, Zi Yang ;
Luong, Amber U. ;
Peng, Weiyi ;
Wang, Jing ;
Balakrishnan, Kumudha ;
Yee, Cassian ;
Dong, Chen ;
Davis, Richard Eric ;
Watowich, Stephanie S. ;
Neelapu, Sattva S. .
LEUKEMIA, 2019, 33 (11) :2640-2653
[25]   Cancer transcriptome profiling at the juncture of clinical translation [J].
Cieslik, Marcin ;
Chinnaiyan, Arul M. .
NATURE REVIEWS GENETICS, 2018, 19 (02) :93-109
[26]  
Csardi G., 2006, InterJournal
[27]   Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data [J].
Dai, MH ;
Wang, PL ;
Boyd, AD ;
Kostov, G ;
Athey, B ;
Jones, EG ;
Bunney, WE ;
Myers, RM ;
Speed, TP ;
Akil, H ;
Watson, SJ ;
Meng, F .
NUCLEIC ACIDS RESEARCH, 2005, 33 (20) :e175.1-e175.9
[28]   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].
Dave, SS ;
Wright, G ;
Tan, B ;
Rosenwald, A ;
Gascoyne, RD ;
Chan, WC ;
Fisher, RI ;
Braziel, RM ;
Rimsza, LM ;
Grogan, TM ;
Miller, TP ;
LeBlanc, M ;
Greiner, TC ;
Weisenburger, DD ;
Lynch, JC ;
Vose, J ;
Armitage, JO ;
Smeland, EB ;
Kvaloy, S ;
Holte, H ;
Delabie, J ;
Connors, JM ;
Lansdorp, PM ;
Ouyang, Q ;
Lister, TA ;
Davies, AJ ;
Norton, AJ ;
Muller-Hermelink, HK ;
Ott, G ;
Campo, E ;
Montserrat, E ;
Wilson, WH ;
Jaffe, ES ;
Simon, R ;
Yang, LM ;
Powell, J ;
Zhao, H ;
Goldschmidt, N ;
Chiorazzi, M ;
Staudt, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169
[29]   Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial [J].
Davies, Andrew ;
Cummin, Thomas E. ;
Barrans, Sharon ;
Maishman, Tom ;
Mamot, Christoph ;
Novak, Urban ;
Caddy, Josh ;
Stanton, Louise ;
Kazmi-Stokes, Shamim ;
McMillan, Andrew ;
Fields, Paul ;
Pocock, Christopher ;
Collins, Graham P. ;
Stephens, Richard ;
Cucco, Francesco ;
Clipson, Alexandra ;
Sha, Chulin ;
Tooze, Reuben ;
Care, Matthew A. ;
Griffiths, Gareth ;
Du, Ming-Qing ;
Westhead, David R. ;
Burton, Catherine ;
Johnson, Peter W. M. .
LANCET ONCOLOGY, 2019, 20 (05) :649-662
[30]   Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy [J].
de Charette, Marie ;
Houot, Roch .
HAEMATOLOGICA, 2018, 103 (08) :1256-1268